Mayanna Lund

2.4k total citations
37 papers, 602 citations indexed

About

Mayanna Lund is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Mayanna Lund has authored 37 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in Mayanna Lund's work include Heart Failure Treatment and Management (19 papers), Cardiac pacing and defibrillation studies (9 papers) and Cardiovascular Function and Risk Factors (8 papers). Mayanna Lund is often cited by papers focused on Heart Failure Treatment and Management (19 papers), Cardiac pacing and defibrillation studies (9 papers) and Cardiovascular Function and Risk Factors (8 papers). Mayanna Lund collaborates with scholars based in New Zealand, Singapore and Australia. Mayanna Lund's co-authors include Robert N. Doughty, Richard W. Troughton, Katrina Poppe, Mark Richards, Carolyn S.P. Lam, Gerry Devlin, Tze Pin Ng, Hean Yee Ong, Fazlur Jaufeerally and Poh Shuan Daniel Yeo and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Mayanna Lund

31 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayanna Lund New Zealand 12 528 100 86 45 45 37 602
Friederike K. Keating United States 13 365 0.7× 41 0.4× 180 2.1× 41 0.9× 70 1.6× 29 567
Sudipta Chattopadhyay United Kingdom 10 410 0.8× 173 1.7× 129 1.5× 17 0.4× 91 2.0× 23 566
Jo Jo Hai Hong Kong 17 598 1.1× 65 0.7× 80 0.9× 84 1.9× 38 0.8× 53 750
Valerio Verdiani Italy 11 460 0.9× 35 0.3× 69 0.8× 54 1.2× 22 0.5× 18 536
Frank G. Aguilar United States 10 539 1.0× 215 2.1× 73 0.8× 42 0.9× 58 1.3× 15 663
Mahmut Şahin Türkiye 13 316 0.6× 108 1.1× 137 1.6× 57 1.3× 42 0.9× 55 498
Damirbek Osmonov Türkiye 14 270 0.5× 45 0.5× 95 1.1× 72 1.6× 66 1.5× 35 445
Stefano Poli Italy 10 313 0.6× 35 0.3× 85 1.0× 41 0.9× 18 0.4× 20 374
Vibeke Kirk Denmark 10 333 0.6× 31 0.3× 52 0.6× 65 1.4× 37 0.8× 12 467
Serkan Öztürk Türkiye 15 315 0.6× 58 0.6× 96 1.1× 73 1.6× 69 1.5× 65 551

Countries citing papers authored by Mayanna Lund

Since Specialization
Citations

This map shows the geographic impact of Mayanna Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayanna Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayanna Lund more than expected).

Fields of papers citing papers by Mayanna Lund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayanna Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayanna Lund. The network helps show where Mayanna Lund may publish in the future.

Co-authorship network of co-authors of Mayanna Lund

This figure shows the co-authorship network connecting the top 25 collaborators of Mayanna Lund. A scholar is included among the top collaborators of Mayanna Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayanna Lund. Mayanna Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pearson, Andree G., John F. Pearson, Lynley K. Lewis, et al.. (2025). Lower NT-Probnp Plasma Concentrations in Pacific Peoples with Heart Failure. ESC Heart Failure. 12(4). 2976–2984.
2.
Pilbrow, Anna P., Chris Frampton, Vicky A. Cameron, et al.. (2024). Plasma Soluble Fms-Like Tyrosine Kinase-1, Placental Growth Factor, and Vascular Endothelial Growth Factor System Gene Variants as Predictors of Survival in Heart Failure. European Journal of Heart Failure. 26(8). 1804–1813. 1 indexed citations
3.
Teramoto, K., Wan Ting Tay, Jasper Tromp, et al.. (2024). Longitudinal NT‐proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure. Journal of the American Heart Association. 13(9). e032254–e032254. 6 indexed citations
4.
Chan, Daniel, Robert N. Doughty, Mayanna Lund, et al.. (2024). https://nzmj.org.nz/journal/vol-137-no-1599/use-of-medications-for-migraine-in-aotearoa-new-zealand. New Zealand Medical Journal. 137(1599). 88–102.
5.
Doughty, Robert N., Gerry Devlin, Selwyn Wong, et al.. (2024). 2023 position statement on improving management for patients with heart failure in Aotearoa New Zealand. New Zealand Medical Journal. 137(1590). 93–99.
6.
Pabón, Maria, Jonathan W. Cunningham, Brian Claggett, et al.. (2023). Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial. JACC Heart Failure. 11(12). 1729–1738. 11 indexed citations
7.
Tan, Eugene S.J., Siew‐Pang Chan, Chris Frampton, et al.. (2023). Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure. JACC Heart Failure. 11(6). 662–674. 8 indexed citations
8.
Bennett, Julie, William Leung, Rachel Webb, et al.. (2022). Medical Treatment for Rheumatic Heart Disease: A Narrative Review. Heart Lung and Circulation. 31(11). 1463–1470. 1 indexed citations
9.
Anderson, Anneka, et al.. (2022). Cohort profile: methodology and cohort characteristics of the Aotearoa New Zealand Rheumatic Heart Disease Registry. BMJ Open. 12(12). e066232–e066232. 1 indexed citations
10.
Doughty, Robert N., Vanessa Selak, Katrina Poppe, et al.. (2022). Identification of clinically relevant cohorts of people with heart failure from electronic health data in Aotearoa: potential, pitfalls and a plan. New Zealand Medical Journal. 135(1563). 96–104.
11.
Yeo, Tee Joo, Lieng Hsi Ling, David Sim, et al.. (2021). Impact of Change in Iron Status Over Time on Clinical Outcomes in Heart Failure According to Ejection Fraction Phenotype. ESC Heart Failure. 8(6). 4572–4583. 25 indexed citations
12.
Chan, Daniel, Robert N. Doughty, Mayanna Lund, Mildred Lee, & Andrew Kerr. (2020). Target Doses of Secondary Prevention Medications Are Not Being Achieved in Patients With Reduced Left Ventricular Ejection Fraction After Acute Coronary Syndrome (ANZACS-QI 34). Heart Lung and Circulation. 29(9). 1386–1396.
13.
Gabriel, R., et al.. (2016). Clinical Characteristics and Outcomes of Patients with Amphetamine-Associated Cardiomyopathy in South Auckland, New Zealand. Heart Lung and Circulation. 25(11). 1087–1093. 14 indexed citations
14.
Troughton, Richard W., et al.. (2015). High prevalence of iron deficiency in heart failure with preserved ejection fraction. Heart Lung and Circulation. 24. S78–S78. 1 indexed citations
15.
16.
French, John K., T.A. Hyde, Jacqueline Andrews, et al.. (2000). Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction. Journal of the American College of Cardiology. 35(6). 1516–1524. 29 indexed citations
17.
Lund, Mayanna. (2000). Serum troponins T and I after elective cardioversion. European Heart Journal. 21(3). 245–253. 47 indexed citations
18.
Andrews, Jacqueline, John K. French, Cindy L. Green, et al.. (2000). ST-Segment Recovery Adds to the Assessment of TIMI 2 and 3 Flow in Predicting Infarct Wall Motion After Thrombolytic Therapy. Circulation. 101(18). 2138–2143. 51 indexed citations
19.
Dixon, Simon, Peter Ruygrok, T. M. Agnew, et al.. (1999). Cardiac allograft vasculopathy: the green lane hospital experience 1987-1998.. PubMed. 112(1099). 417–20. 3 indexed citations
20.
Macdonald, Peter S., et al.. (1999). Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure. Journal of the American College of Cardiology. 33(4). 924–931. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Friederike K. Keating Breakdown of academic impact, for papers by Sudipta Chattopadhyay Breakdown of academic impact, for papers by Jo Jo Hai Breakdown of academic impact, for papers by Valerio Verdiani Breakdown of academic impact, for papers by Frank G. Aguilar Breakdown of academic impact, for papers by Mahmut Şahin Breakdown of academic impact, for papers by Damirbek Osmonov Breakdown of academic impact, for papers by Stefano Poli Breakdown of academic impact, for papers by Vibeke Kirk Breakdown of academic impact, for papers by Serkan Öztürk
Rankless by CCL
2026